Home


By connecting our clients with the resources they need to support scientific advancement, EGC seeks to break down the barriers that exist in translating great scientific discoveries into solutions that can solve our society’s most pressing problems. Our team’s strategic, targeted approach has supported clients in securing and managing over $1 Billion in grants and contracts that fund some of the most innovative research & development in the US and worldwide.
Latest News
EGC’s Dr. Heaney Presents at BioVenture Nexus in LA
On October 5-6, 2023, the EGC Team will be attending BioVenture Nexus located at the JW Marriott-The Ritz Carlton Los Angeles, CA. BioVenture Nexus is the premier event for innovation and networking in the Synthetic Biology, Biotech Industry, Life Science, Food Tech,...
EGC Receives Six-Time Inc. 5000 Recognition
Eva Garland Consulting, LLC (EGC) is excited once again to be named as one of the fastest growing privately owned companies in the United States by capturing a spot on the Inc. 5000 list for the sixth consecutive year. We are extremely grateful for our of 55 employees...
EGC’s Leadership of NIH AAP Enters 5th Year
Eva Garland Consulting (EGC) is thrilled to extend our partnership with the National Institutes of Health (NIH) to support small businesses in developing SBIR/STTR proposals through the NIH Applicant Assistance Program (AAP). Currently in its 5th year, the AAP has...
EGC Presents at a NCATS Workshop on Non-Dilutive Funding
On Monday, June 26, at 1:00 p.m. ET., Dr. Xiaohu (Tiger) Xie, a Scientific Grants Expert from Eva Garland Consulting, will present a talk titled “Application Tips & Resources to Help Secure SBIR & STTR Funding”, sponsored by the NIH’s National Center for...